Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,467 | -9,470 | -3,843 | -7,508 | -4,409 |
| Depreciation Amortization | 179 | 424 | 229 | 554 | 250 |
| Other Working Capital | 257 | 255 | -57 | -848 | -63 |
| Other Operating Activity | -828 | 73 | -773 | -460 | -122 |
| Operating Cash Flow | $-4,859 | $-8,718 | $-4,443 | $-8,262 | $-4,344 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -52 | -30 | -382 | -205 |
| Other Investing Activity | 30 | -220 | 9 | 0 | 0 |
| Investing Cash Flow | $25 | $-272 | $-21 | $-382 | $-205 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 7,828 | 58 | -98 | 12,108 | -113 |
| Financing Cash Flow | $7,828 | $58 | $-98 | $12,108 | $-113 |
| Exchange Rate Effect | N/A | 0 | N/A | -11 | -8 |
| Beginning Cash Position | 3,551 | 12,440 | 12,627 | 10,377 | 10,548 |
| End Cash Position | 6,545 | 3,508 | 8,064 | 13,829 | 5,876 |
| Net Cash Flow | $2,994 | $-8,932 | $-4,562 | $3,453 | $-4,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,859 | -8,718 | -4,443 | -8,262 | -4,344 |
| Free Cash Flow | -4,859 | -8,718 | -4,443 | -8,262 | -4,344 |